Bähr, O., Hattingen, E., Rieger, J., & Steinbach, J. P. (2011). Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Oxford University Press.
Citación estilo ChicagoBähr, Oliver, Elke Hattingen, Johannes Rieger, y Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Cita MLABähr, Oliver, Elke Hattingen, Johannes Rieger, y Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Precaución: Estas citas no son 100% exactas.